Division of Pediatric Allergy Immunology and Pulmonary Medicine Archive — Page 2 of 3

Child kissing and touching a pregnant adult’s abdomen.
March 16, 2023

Study seeks to identify prenatal allergy risk markers

A Vanderbilt clinical trial is seeking to identify prenatal and early childhood markers of high risk for food allergy and atopic dermatitis, or eczema, as well as biological pathways that lead to these conditions.

By Jessica Pasley
Paula Ciero poses in a hallway, wearing a bright lime-green sweatshirt and dark pants.
December 6, 2022

Paula Ciero fun toy toolkit puts children at ease during clinic visits

From fidget bracelets to sound tubes to “squishies,” Ciero finds ways to make children smile.

By Christina Echegaray
Close-up of a pregnant person in a light pink jacket and white top resting both hands on their belly.
November 10, 2022

Study to explore nasal bacteria of children born by C-section

Vanderbilt is recruiting pregnant women scheduled to undergo a repeat cesarean section at VUMC for a study of potential interventions to change the bacteria living in the nose of children born by C-section.

By Nancy Humphrey
Javion Johnson, a patient at Children’s Hospital’s Duchenne Muscular Dystrophy Clinic, holds a plaque designating the clinic as a Certified Care Center. Others on hand include from left, his father Ronnie Johnson, mother, Xavier Verge, brother, J’zarion Williams, Andrew Sokolow, MD, Bryan Burnette, MD, Jonathan Soslow, MD, Kali Barbalena and Haleigh Southern, RN.
March 31, 2022

Vanderbilt’s Duchenne Clinic first in Tennessee to be certified

The Duchenne Muscular Dystrophy Clinic at Monroe Carell Jr. Children’s Hospital at Vanderbilt has been recognized as a Certified Duchenne Care Center Program by the Parent Project Muscular Dystrophy, and is the only center in Tennessee to receive the distinction.

By Jessica Pasley
Open orange prescription bottle spilling green-and-white capsules onto a white surface.
February 28, 2022

Study finds azithromycin use during RSV not useful in preventing recurrent wheezing, may cause harm

Vanderbilt research on the impact of the antibiotic azithromycin during severe respiratory syncytial virus (RSV) bronchiolitis overwhelmingly support current national bronchiolitis guidelines, which recommend against antibiotics during acute bronchiolitis due to lack of effect on the acute illness.

By Jessica Pasley
Illustration of three inhaler devices in orange, blue, and light blue, shown upright and at an angle.
December 8, 2021

International study supports dupilumab for treatment of moderate-to-severe asthma in children

In a late-stage clinical trial, the biologic agent dupilumab reduced the rate of severe asthma attacks and improved lung function and asthma control for children ages 6 to 11 with moderate-to-severe asthma, offering a new option to these patients.

By Leigh MacMillan